BioAdvance was awarded $33.8 million from the Commonwealth’s share of tobacco settlement monies to grow the life sciences industry in Southeastern Pennsylvania. Fulfilling this mission, BioAdvance is:
Investing in emerging life sciences technologies with the most promising commercialization prospects.
Accelerating the transfer of technology from research laboratories to start-ups and established companies.
Building collaborations between academic, entrepreneurial, corporate, financial, and government partners.
Attracting, retaining, and supporting life sciences entrepreneurs.
BioAdvance has allocated $20 million to its Greenhouse Fund, which provides between $5,000 and $500,000 investments in new therapeutics, biomedical devices, diagnostics and platform technologies that have the potential of improving human health. Another $2.5 million is allocated to each of two initiatives that build on the region’s unmatched base of academic institutions, research facilities, hospitals and its biosciences industry. One initiative is focused on the emerging field of bioinformatics and the second supports increased access to the region’s clinical trials capabilities.
| Contact Details: |
| Corporation of Southeastern Pennsylvania3701 Market Street |
| Philadelphia |
| Pennsylvania |
| 19104 |
| United States of America |
| Tel: | (215) 966-6214 |
| Fax: | (215) 966-6215 |
| Email: | info@bioadvance.com |
| WWW: | www.bioadvance.com/
|
|
Loading...
|
Press Releases on BioAdvance:
|
 |
| ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors |
8th June, 2009 |
ViroPharma Incorporated |
EXTON, Pa., June 8 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the appointment of Frank Baldino, Jr., Ph.D. to its board of directors.
Dr. Baldino brings several
|
| Tengion CEO Dr. Steven Nichtberger Wins Ernst & Young National Entrepreneur Of The Year(R) Award |
17th November, 2008 |
Tengion, Inc. |
EAST NORRITON, Pa., Nov. 17 /PRNewswire/ -- Tengion, Inc., a clinical
stage biotechnology company focused on the development of neo-organs and
neo-tissues, today announced that its Co-founder,
|
| TheraQuest Presents Topical Local Anesthetic and Abuse Deterrence Data at the World Congress on Pain |
20th August, 2008 |
TheraQuest Biosciences, Inc. |
BLUE BELL, Pa., Aug. 20 /PRNewswire/ -- TheraQuest Biosciences, Inc. a
development stage pain management company is presenting data today on TQ-1019,
its proprietary topical local anesthetic and
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 254 times since April 2007, the link to the organisation's website has been followed 48 times
Recent Search Terms used to find this page: TQ1019 TheraQuest Biosciences | bioavance | promote bioavance | bioadvance | bioadvance | BioAdvance | BIOADVANCE | BIOADVANCE | BioAdvance entrepreneurs opinion | novira therapeutics, Philadelphia, PA 19104 | .
Search for more companies in Philadelphia
Search for more companies in Pennsylvania
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
BioAdvance
